Platelet-Activating Factor Receptor Ligands Protect Tumor Cells from Radiation-Induced Cell Death

Overview

Journal Front Oncol

Specialty Oncology

Date 2018 Feb 21

PMID 29459885

Citations 12

Authors

Ildefonso Alves da Silva-Junior

Barbara Dalmaso

Suellen Herbster

Ana Paula Lepique

Sonia Jancar

Affiliations

Soon will be listed here.

Abstract

Irradiation generates oxidized phospholipids that activate platelet-activating factor receptor (PAFR) associated with pro-tumorigenic effects. Here, we investigated the involvement of PAFR in tumor cell survival after irradiation. Cervical cancer samples presented higher levels of PAF-receptor gene (PTAFR) when compared with normal cervical tissue. In cervical cancer patients submitted to radiotherapy (RT), the expression of PTAFR was significantly increased. Cervical cancer-derived cell lines (C33, SiHa, and HeLa) and squamous carcinoma cell lines (SCC90 and SCC78) express higher levels of PAFR mRNA and protein than immortalized keratinocytes. Gamma radiation increased PAFR expression and induced PAFR ligands and prostaglandin E2 (PGE2) in these tumor cells. The blocking of PAFR with the antagonist CV3938 before irradiation inhibited PGE2 and increased tumor cells death. Similarly, human carcinoma cells transfected with PAFR (KBP) were more resistant to radiation compared to those lacking the receptor (KBM). PGE2 production by irradiated KBP cells was also inhibited by CV3988. These results show that irradiation of carcinoma cells generates PAFR ligands that protect tumor cells from death and suggests that the combination of RT with a PAFR antagonist could be a promising strategy for cancer treatment.

Citing Articles

Impact of targeting the platelet-activating factor and its receptor in cancer treatment.

Qaderi K, Shahmoradi A, Thyagarajan A, Sahu R Mil Med Res. 2025; 12(1):10.

PMID: 40033370 PMC: 11877967. DOI: 10.1186/s40779-025-00597-0.

NF-κB in the Radiation Response of A549 Non-Small Cell Lung Cancer Cells to X-rays and Carbon Ions under Hypoxia.

Nisar H, Sanchidrian Gonzalez P, Labonte F, Schmitz C, Roggan M, Kronenberg J Int J Mol Sci. 2024; 25(8).

PMID: 38674080 PMC: 11050661. DOI: 10.3390/ijms25084495.

PAIP1 regulates expression of immune and inflammatory response associated genes at transcript level in liver cancer cell.

Zheng J, Fan W, Zhang X, Quan W, Wu Y, Shu M PeerJ. 2023; 11:e15070.

PMID: 37101794 PMC: 10124545. DOI: 10.7717/peerj.15070.

Sequential anti-inflammatory and osteogenic effects of a dual drug delivery scaffold loaded with parthenolide and naringin in periodontitis.

Chen R, Wang M, Qi Q, Tang Y, Guo Z, Wu S J Periodontal Implant Sci. 2022; 53(1):20-37.

PMID: 36468470 PMC: 9943701. DOI: 10.5051/jpis.2105700285.

Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells.

de Freitas Saito R, Andrade L, Bustos S, Chammas R Front Immunol. 2022; 13:768606.

PMID: 35250970 PMC: 8889569. DOI: 10.3389/fimmu.2022.768606.

References

McIntyre T . Bioactive oxidatively truncated phospholipids in inflammation and apoptosis: formation, targets, and inactivation. Biochim Biophys Acta. 2012; 1818(10):2456-64. PMC: 3389264. DOI: 10.1016/j.bbamem.2012.03.004. View

Donato A, Huang Q, Liu X, Li F, Zimmerman M, Li C . Caspase 3 promotes surviving melanoma tumor cell growth after cytotoxic therapy. J Invest Dermatol. 2014; 134(6):1686-1692. PMC: 4020991. DOI: 10.1038/jid.2014.18. View

Sahu R, Harrison K, Weyerbacher J, Murphy R, Konger R, Garrett J . Radiation therapy generates platelet-activating factor agonists. Oncotarget. 2016; 7(15):20788-800. PMC: 4991492. DOI: 10.18632/oncotarget.7878. View

Tripathi Y, Kandala J, Guntaka R, Lim R, Shukla S . Platelet activating factor induces expression of early response genes c-fos and TIS-1 in human epidermoid carcinoma A-431 cells. Life Sci. 1991; 49(23):1761-7. DOI: 10.1016/0024-3205(91)90319-7. View

Yao Y, Wolverton J, Zhang Q, Marathe G, Al-Hassani M, Konger R . Ultraviolet B radiation generated platelet-activating factor receptor agonist formation involves EGF-R-mediated reactive oxygen species. J Immunol. 2009; 182(5):2842-8. PMC: 2750830. DOI: 10.4049/jimmunol.0802689. View

Giaginis C, Kourou E, Giagini A, Goutas N, Patsouris E, Kouraklis G . Platelet-activating factor (PAF) receptor expression is associated with histopathological stage and grade and patients' survival in gastric adenocarcinoma. Neoplasma. 2014; 61(3):309-17. DOI: 10.4149/neo_2014_040. View

Sato S, Kume K, Ito C, Ishii S, Shimizu T . Accelerated proliferation of epidermal keratinocytes by the transgenic expression of the platelet-activating factor receptor. Arch Dermatol Res. 2000; 291(11):614-21. DOI: 10.1007/s004030050463. View

Prescott S, Zimmerman G, Stafforini D, McIntyre T . Platelet-activating factor and related lipid mediators. Annu Rev Biochem. 2000; 69:419-45. DOI: 10.1146/annurev.biochem.69.1.419. View

Maggi M, Bonaccorsi L, Finetti G, Carloni V, Muratori M, Laffi G . Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A. Cancer Res. 1994; 54(17):4777-84. View

10.

Liou J, Ellent D, Lee S, Goldsby J, Ko B, Matijevic N . Cyclooxygenase-2-derived prostaglandin e2 protects mouse embryonic stem cells from apoptosis. Stem Cells. 2007; 25(5):1096-103. DOI: 10.1634/stemcells.2006-0505. View

11.

Huang Q, Li F, Liu X, Li W, Shi W, Liu F . Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med. 2011; 17(7):860-6. PMC: 3132290. DOI: 10.1038/nm.2385. View

12.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

13.

Mutoh H, Ishii S, Izumi T, Kato S, Shimizu T . Platelet-activating factor (PAF) positively auto-regulates the expression of human PAF receptor transcript 1 (leukocyte-type) through NF-kappa B. Biochem Biophys Res Commun. 1994; 205(2):1137-42. DOI: 10.1006/bbrc.1994.2784. View

14.

Lalouette F, Diserbo M, Martin C, Verdetti J, Fatome M . Presence of specific platelet-activating factor binding-sites in neuroblastoma N1E-115 cells. Neurosci Lett. 1995; 186(2-3):173-6. DOI: 10.1016/0304-3940(95)11319-r. View

15.

Onuchic A, Machado C, Saito R, Rios F, Jancar S, Chammas R . Expression of PAFR as part of a prosurvival response to chemotherapy: a novel target for combination therapy in melanoma. Mediators Inflamm. 2012; 2012:175408. PMC: 3337612. DOI: 10.1155/2012/175408. View

16.

Yamamori T, Yasui H, Yamazumi M, Wada Y, Nakamura Y, Nakamura H . Ionizing radiation induces mitochondrial reactive oxygen species production accompanied by upregulation of mitochondrial electron transport chain function and mitochondrial content under control of the cell cycle checkpoint. Free Radic Biol Med. 2012; 53(2):260-70. DOI: 10.1016/j.freeradbiomed.2012.04.033. View

17.

Yu Y, Zhang M, Zhang X, Cai Q, Hong S, Jiang W . Synergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cells. J Hematol Oncol. 2014; 7:39. PMC: 4028110. DOI: 10.1186/1756-8722-7-39. View

18.

Ferracini M, Sahu R, Harrison K, Waeiss R, Murphy R, Jancar S . Topical photodynamic therapy induces systemic immunosuppression via generation of platelet-activating factor receptor ligands. J Invest Dermatol. 2014; 135(1):321-323. PMC: 4268233. DOI: 10.1038/jid.2014.313. View

19.

Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S . Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res. 1998; 58(17):3761-4. View

20.

Mohanti B, Thakar A, Kaur J, Bahadur S, Malik M, Gandhi A . Postoperative radiotherapy dose requirement in standard combined-modality practice for head and neck squamous cell carcinoma: Analysis of salient surgical and radiotherapy parameters in 2 cohorts. Head Neck. 2017; 39(9):1788-1796. DOI: 10.1002/hed.24836. View